ABSTRACT-Effects of REM sleep (REMs) deprivation on the basal swimming activity and the tricyclic anti depressants-induced increase in swimming activity in the forced swimming test were investigated. Im mediately after a 48-hr period of REMs deprivation, the basal swimming activity in REMs-deprived mice was significantly higher than those in group-housed and socially isolated animals used as the control groups. The REMs deprivation-induced increase in the swimming activity was not changed by adrenoceptor an tagonists and it returned to the control levels 3 hr after the REMs deprivation treatment. Moreover, imipra mine and desipramine but not clomipramine further increased the swimming activity enhanced by REMs deprivation at doses that did not affect the activity in the control groups. The enhancing effect of REMs deprivation on the sensitivity to imipramine and desipramine remained unchanged even at 3 hr after the REMs deprivation treatment, and it was blocked by the a2-adrenoceptor antagonist yohimbine. These results suggest that the REMs deprivation-induced increase in basal swimming activity in the forced swim ming test is not mediated by adrenoceptor mechanisms, whereas the enhancing effect of REMs deprivation on the sensitivity to imipramine and desipramine may be mediated by the functional changes in a2 adrenoceptors in the brain. . Therefore, these similarities between the effects of REMs deprivation and those of chronic anti depressants raise the possibility that the antidepressants like effect of REMs deprivation in the forced swimming test may be mediated by the same mechanism(s) as those of antidepressant drugs, and that combination of REMs deprivation with antidepressant drug treatment may modi fy the effects of antidepressant drugs.
REM sleep (REMs) deprivation has been clinically shown to improve certain types of depression in humans (for a review, see ref. 1) . In rodents, this treatment de creases the immobility time (or increases the swimming activity) in the forced swimming test (2-6), a primary method for screening antidepressant drugs originally introduced by Porsolt et al. (7) . REMs deprivation seems to have similar effects to those of tricyclic antidepressant drugs on the central noradrenergic system in other behav ioral and neurochemical experiments. REMs deprivation as well as chronic antidepressant drug treatment attenu ates the sedation induced by clonidine, an a2-adrenocep tor agonist (8; for a review, see ref. 9) . In in vitro studies, REMs deprivation treatment reduced the accumulation of cyclic AMP stimulated by noradrenaline and decreased the density of 13-adrenoceptors in the cortex of rats (for a review, see ref. 10 ). These neurochemical changes in duced by REMs deprivation have also been demonstrated in the rats pretreated with antidepressant drugs (for a review, see ref. 9 ). Therefore, these similarities between the effects of REMs deprivation and those of chronic anti depressants raise the possibility that the antidepressants like effect of REMs deprivation in the forced swimming test may be mediated by the same mechanism(s) as those of antidepressant drugs, and that combination of REMs deprivation with antidepressant drug treatment may modi fy the effects of antidepressant drugs.
We undertook the present study to determine whether an adrenoceptor mechanism is commonly involved in the REMs deprivation and the tricyclic antidepressant drugs induced increase in swimming activity in the forced swim ming test. Furthermore, to clarify whether REMs depriva tion modifies the effect of an antidepressant drug, we test ed the effects of REMs deprivation on the imipramine-, desipramine and clomipramine-induced increase in swim ming activity.
MATERIALS AND METHODS

Animals
Male 5-week-old ddY mice (Japan SLC, Inc., Hamamatsu) were used in the experiments. The animals were housed in groups of 20-25 per cage (35 x 30 x 16 cm), for at least 1 week before the start of the experiment, with free access to food and water. Housing conditions were thermostatically maintained at 24 ± 1 C , with a 12-hr light/dark cycle (light on 07 : 30-19 : 30).
REM sleep deprivation
Mice were deprived of REMs by the small pedestal (plat form) method as described previously (6, 11) . In brief, a small pedestal (4.5-cm-high, 1.8 cm in diameter) was fixed at the center of a REMs deprivation chamber (20 x 15 x 21 cm) and was surrounded by water (3.5-cm-deep). A group of mice was placed individually in the chamber and housed for 48 hr with free access to food and water (REMs-deprived mice). During the REMs deprivation period, other groups of mice were either housed in groups of four (group-housed mice) or housed individually (iso lated mice) in a Plexiglas cage (25 x 18 x 12 cm), and they were used as the control groups. After the termination of REMs deprivation, each mouse was placed individually in the Plexiglas cage for 3 hr, with the exception of the animals used for immediate experimentation.
The forced swimming test
Each mouse was placed individually in a transparent glass cylinder (20-cm-high, 8 cm in diameter) containing fresh water (251C, 8-cm-deep) and was forced to swim for 15 min (pretest swimming). After a 20-min drying period, the animals were deprived of REMs for 48 hr. Immediate ly after the termination of REMs deprivation or after a 3 hr recovery period, the animals were placed in the cylin der for 5 min (test swimming). Swimming activity during the test was measured using an animal movement analyz ing system, Scanet SV-10 (Toyo Sangyo Co., Ltd., Toyama), as described previously (6) . In brief, this system consisted of a rectangular enclosure (40 x 38 cm), the side walls (12 cm) of which were equipped with 144 pairs of photosensors. Each pair of photosensors was set at a height of 8.8 cm above the floor, and was scanned every 0.1 sec to detect animal movement. Swimming activity was calculated from the scanning data obtained.
Drugs
Phentolamine mesylate (Regitine® Inj.; Japan Ciba Geigy, Ltd., Takarazuka), yohimbine HCl and DL-pro pranolol HCl (Nacalai Tesque, Inc., Kyoto) were ad ministered at 1 hr prior to testing. Imipramine HCI, desipramine HCI, and clomipramine HCI (Sigma Chemi cal Co., St. Louis, MO, USA) were given immediately af ter the pretest swimming and at 24, 5 and 1 hr before the test swimming. All drugs were dissolved in or diluted with saline just before the experiments and were intraperito neally injected using a constant volume (0.01 ml/g body weight).
Statistical analysis
Swimming activity in the test swimming was analyzed by one-way analysis of variance (ANOVA) followed by the two-tailed multiple Student's t-test. Differences of P < 0.05 were considered significant. Table 1 .
The effects of adrenoceptor antagonists on the REM sleep deprivation-induced increase in swimming activity
RESULTS
The effects of adrenoceptor antagonists on the REMs deprivation and tricyclic antidepressant drugs-induced in crease in swimming activity As previously reported (6), when tested immediately after the termination of REMs deprivation treatment, a significant increase in the basal swimming activity was observed in REMs-deprived mice. The REMs deprivation induced increase in basal swimming activity was not changed by yohimbine, an a2-adrenoceptor antagonist; phentolamine (5, 10, and 20 mg/kg), an a-adrenoceptor antagonist; or propranolol (5, 10, and 30 mg/kg), a j3 adrenoceptor antagonist (Table 1) . Repeated administration of imipramine (20, 30 , and 40 mg/kg, x 4), a noradrenaline and serotonin uptake block er, and desipramine (10, 20 , and 30 mg/kg, x 4), a selec tive noradrenaline uptake blocker, dose-dependently in creased the swimming activity in the group-housed con trol mice. The dose-response curve of clomipramine (20, 30 , and 40 mg/kg, x 4), a preferential serotonin uptake blocker, was bell-shaped; and the effect of this drug was statistically significant only at a dose of 30 mg/kg (Fig.  1) . Yohimbine (5 mg/kg) significantly decreased the swim ming activity enhanced by imipramine (40 mg/kg, x 4) and desipramine (30 mg/kg, x 4) in the group-housed control animals. However, this antagonist did not affect the clomipramine (30 mg/kg, x 4)-induced increase in swimming activity (Table 2) . The effects of imipramine, desipramine, and clomipra mine on the swimming activity in REMs-deprived mice When tested immediately after REMs deprivation treat ment, repeated administration of imipramine (20 mg/kg, x 4) further increased the basal swimming activity en hanced by REMs deprivation, while it did not affect the activity in the group-housed or isolated animals ( Fig.  2A) . Desipramine (10 mg/kg, x 4) also significantly in creased the swimming activity in the REMs-deprived mice at a dose that did not affect the activity in the control groups (Fig. 2B) .
Three hours after the termination of REMs deprivation treatment, the basal swimming activity in the REMs deprived mice returned to the control levels, but repeated administration of imipramine (20 mg/kg, x 4) and desipramine (10 mg/kg, x 4) still significantly increased the swimming activity in REMs-deprived mice (Fig. 3, A  and B ).
Clomipramine at a dose of 20 mg/kg, x 4 did not in crease the swimming activity in REMs-deprived mice, whereas at a higher dose (30 mg/kg, x 4), this drug sig nificantly increased the activity in REMs-deprived animals. However, there was no significant difference in the latter effect between REMs-deprived animals and the control groups (Figs. 4 and 5) . obtained from 16 animals. **P<0 .01, compared to each group; N.S P>0.05, compared to the saline-treated group-housed and isolated animals (multiple Student's t-test). The effects of yohimbine and propranolol on the imipra mine and desipramine-induced increase in swimming activity in REM sleep-deprived mice Yohimbine (5 mg/kg) did not change the basal swim ming activity when examined 3 hr after the REMs depriva tion treatment. This antagonist significantly blocked the effects of imipramine (20 mg/kg, x 4) and desipramine (10 mg/kg, x 4) on the swimming activity in REMs deprived mice (Table 3) . On the other hand, propranolol (5, 10, and 30 mg/kg) did not affect either the basal swim ming activity or the desipramine (10 mg/kg, x 4)-induced increase in the swimming activity in REMs-deprived mice (Table 4) . Table 4 .
The effect of propranolol on the desipramine-induced in crease in swimming activity in REM sleep-deprived mice
DISCUSSION
As previously reported (6), the basal swimming activity in REMs-deprived mice was significantly higher than those in group-housed and isolated control animals, when examined immediately after the termination of REMs derivation. Since stimulation of adrenoceptors has been reported to play an important role in the anti-immobility effect in the forced swimming test (6, (12) (13) (14) (15) , it is pos sible that REMs deprivation may increase the tonic activ ity of the noradrenergic system in the brain, resulting in an increase in the basal swimming activity. However, this does not seem to be the case, because in the present study, neither phentolamine (a-adrenoceptor antagonist), yohim bine (a2-adrenoceptor antagonist) nor propranolol (j3 adrenoceptor antagonist) changed the basal swimming activity enhanced by REMs deprivation. The present find ings are in contrast to the data reported by Van Luijtelaar and Coenen (5) that phentolamine (10 mg/kg) prevents the REMs deprivation-induced decrease in immobility time in the forced swimming test. The reasons for the dis crepancy between their data and our results remain un clear, but it may be due to the differences in animal spe cies, REMs deprivation method, injection and test tim ing, and/or method to detect animal behavior. On the other hand, the tricyclic antidepressant drugs used in the present study also significantly increased the swimming activity in the group-housed control mice. Consistent with the data demonstrating the involvement of an a2 adrenoceptor mechanism in the anti-immobility effect of desipramine (16) , the effects of imipramine (40 mg/kg, x 4), a noradrenaline and serotonin uptake blocker, and desipramine (30 mg/kg, x 4), a selective noradrenaline up take blocker, but not of clomipramine (30 mg/kg, x 4), a preferential serotonin uptake blocker, on the swimming activity in group-housed control animals were blocked by yohimbine. Therefore, the present findings indicate that the mechanisms of the increase in swimming activity in duced by REMs deprivation and clomipramine are differ ent from those induced by imipramine and desipramine.
In the REMs-deprived mice, repeated administration of imipramine and desipramine further increased the basal swimming activity at the doses that did not change the swimming activity in the control groups. It should be noted that such enhancing effects of REMs deprivation was long-lasting and remained unchanged for at least 3 hr, whereas the effect of REMs deprivation on the basal swim ming activity was short-lasting, and it had already disap peared by the time the animals were examined at 3 hr after the termination of REMs deprivation treatment. These results indicate that: 1) REMs deprivation potenti ates the effects of imipramine and desipramine on the swimming activity in the forced swimming test, and 2) the mechanism of the increase in basal swimming activity by REMs deprivation can be experimentally distinguished from those of hypersensitivity to imipramine and desipra mine in REMs-deprived mice.
At least two possibilities could account for the increase in imipramine and desipramine sensitivity by REMs depri vation. First, REMs deprivation may cause pharmaco kinetic changes that result in the apparent increase of the sensitivity to imipramine and desipramine. In fact, stress ful manipulations have been reported to affect drug metabolism (17, 18) . However, this possibility seems un likely, since REMs deprivation did not change the effec tive dose of clomipramine that is metabolized by the same pathway as imipramine (19) . Secondly, REMs depriva tion may induce the functional changes in the central nerv ous system in the mouse brain. In the present study, yohimbine inhibited the REMs deprivation-induced in crease in the sensitivity to imipramine and desipramine, suggesting that REMs deprivation causes functional changes in brain a2-adrenoceptors. This idea seems to be supported by our previous data that REMs deprivation en hances the clonidine (a2-adrenoceptor agonist)-induced in crease in swimming activity in the forced swimming test (6) . On the other hand, a ~-adrenoceptor mechanism has been shown to be involved in the anti-immobility effects of antidepressant drugs such as desipramine and amitrip tyline (20, 21) . However, a single administration of pro pranolol failed to inhibit the effect of desipramine (10 mg/kg, x 4) on swimming activity in REMs-deprived mice, suggesting that a ~-adrenoceptor mechanism is not involved in the REMs deprivation-induced increase in desipramine sensitivity.
In conclusion, the present data indicate that REMs deprivation increases the basal swimming activity and potentiates the effect of imipramine and desipramine on swimming activity. The former effect is short-lasting and mediated by non-adrenoceptor mechanisms, whereas the latter is long-lasting and mediated by the REMs depriva tion-induced functional change in a2-adrenoceptors.
